Posts

• Register Now: “Using Oils to Protect Your Chemical Investment”

  Webinar Registration is Open! Adjuvant Advantage for the Sales Agronomist Series Please help us support ARA by strongly encouraging all… Read more…

• SAVE THE DATE: CPDA 2023 Adjuvants & Inerts Conference

  SAVE THE DATE: CPDA 2023 Adjuvants & Inerts Conference

• 2022 A Year in Review

  https://cpda.com/wp-content/uploads/2022/12/2022-Wrapped.mov

• CPDA News & Notes – December 20, 2022

• APPLICATION ENHANCEMENT CERTIFICATION PROGRAM ANNOUNCEMENT

  Apply TodayProgram InformationAPPLICATION ENHANCEMENT CERTIFICATION PROGRAM ANNOUNCEMENT Now Accepting Applications! The first round of testing for Application Enhancement Certification begins… Read more…

• Jay Vroom Joins CPDA as Strategic Advisor

• EPA Updates New Chemical Review Program Webpage, Metrics, Affirming Commitment to Increased Transparency

  EPA Updates New Chemical Review Program Webpage, Metrics, Affirming Commitment to Increased Transparency December 15, 2022 Contact Information EPA Press… Read more…

• EPA Stops Use of 12 PFAS in Pesticide Products

  EPA Stops Use of 12 PFAS in Pesticide Products Released on December 14, 2022 Today, to better protect human health… Read more…

• Changing Application Technologies Push Adjuvants to New Era

  Changing Application Technologies Push Adjuvants to New Era

• CPDA December Bi-Weekly News & Notes

  CPDA News & Notes  

• CPDA Participates in Sign-On Letter: PRIA 5 Letter of Support to Senate and House Ag

  CPDA Participates in Sign-On Letter: PRIA 5 Letter of Support to Senate and House Ag

• EPA Publishes Thousands of Additional TSCA Risk, New Chemicals Submissions, Commits to Near Real-Time Publication Going Forward

  EPA Publishes Thousands of Additional TSCA Risk, New Chemicals Submissions, Commits to Near Real-Time Publication Going Forward The U.S. Environmental… Read more…

• FIFRA Federal-State Preemption Sign-On Letter

  FIFRA Federal-State Preemption Sign-On Letter

• CPDA November News & Notes

• Changing Application Technologies Push Adjuvants to New Era